Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
Accenture
Farmers Insurance
Covington
AstraZeneca
Argus Health
Daiichi Sankyo
Cantor Fitzgerald

Generated: January 16, 2019

DrugPatentWatch Database Preview

Drug Master Files for: ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

« Back to Dashboard


ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE Drug Master Files

DMF No. Status Type Submission Date Holder Subject
11436 I II 4/5/1995 GRANULES INDIA LTD COMPRESSO-90-P (ACETAMINOPHEN GRANULES 90%)
11513 I II 5/11/1995 GRANULES INDIA LTD COMPRESSO-90-CP(F) (ACETAMINOPHEN GRANULES 90%)
12025 I II 7/3/1996 WATSON LABORATORIES INC HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, 10 MG\650 MG
12366 I II 2/5/1997 MATERIALS PROCESSING TECHNOLOGY INC DIRECTLY COMPRESSIBLE ACETAMINOPHEN DC-90B
12367 I II 2/5/1997 MATERIALS PROCESSING TECHNOLOGY INC DIRECTLY COMPRESSIBLE ACETAMINOPHEN DC-90A
14638 I II 12/16/1999 INDUSTRIAS MONFEL SA DE CV ACETAMINOPHEN
DMF No. Status Type Submission Date Holder Subject

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Colorcon
Chubb
Farmers Insurance
Julphar
Harvard Business School
McKesson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.